Leukocyte and Platelet-Rich Fibrin (LPRF) Therapy & Leprosy:


LPRF; Leukocyte and Platelet-Rich Fibrin Therapy; Leprosy; Nepal; Resistance

How to Cite

Houghton F, Moran Stritch M, Tamang K, Winterburn M. Leukocyte and Platelet-Rich Fibrin (LPRF) Therapy & Leprosy:. mir [Internet]. 15Mar.2023 [cited 12Jun.2024];30(119):86-1. Available from: https://interrev.com/mir/index.php/mir/article/view/207


This paper discusses the potential of Leukocyte and Platelet-Rich Fibrin Therapy (LPRF) to help treat ulcers and skin damage associated with leprosy. It warns that although LPRF may be a valuable and cost-effective treatment, it is crucial to understand potential resistance to haematologically based treatments. For physicians and health service staff operating within a biomedical paradigm, folk beliefs resisting such treatments may be inconsequential. However, research and education among marginalised and excluded populations is vital to overcome potential hesitancy and resistance to such treatments.